Objective To explore the clinical characteristics of patients with ankylosing spondylitis (AS) and concomitant hyperuricemia. Methods The clinical data of 169 AS patients were retrospectively analyzed. Patients were divided into hyperuricemia group and normal uric acid group according to the presence of hyperuricemia. The ankylosing spondylitis disease activity (ASDAS⁃CRP or ASDAS⁃ESR) scores, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score, and Bath Ankylosing Spondylitis Functional Index (BASFI) score were adopted to evaluate the disease progression of patients. The sacroiliac grading situation, the Spondyloarthritis Research Consortium of Canada (SPARCC) and SPARCC Sacroiliac Joint Structural Score (SPARCC⁃SSS) were employed to evaluate sacroiliac joints inflammation and structural injury. The clinical data, laboratory indices, disease activity, sacroiliac joints inflammation and structural injury were compared between patients of the two groups. The correlation of blood uric acid level with the disease severity of patients was analyzed. Results Among 169 patients, 38 (22.49%) patients were complicated with hyperuricemia. Age and serum total protein level of patients in the hyperuricemia group were lower than those in the normal uric acid group, and the proportion of males, red blood cell counts and serum creatinine level were higher than those in the normal uric acid group (P<0.05). The BASDAI score of the hyperuricemia group was lower than that of the normal uric acid group (P<0.05), but there was no statistically significant difference in sacroiliitis grading situation, SPARCC sacroiliac joints inflammation score, SPARCC⁃SSS score, ASDAS⁃CRP score, ASDAS⁃ESR score, and BASFI score between the two groups (P>0.05). The results of correlation analysis revealed that the blood uric acid level of AS patients negatively correlated with BASDAI score (P<0.05), but not correlated with ASDAS⁃CRP score, ASDAS⁃ESR score, or BASFI score (P>0.05). Conclusion Compared with patients with normal uric acid, AS patients and concomitant hyperuricemia exhibit clinical characteristics in terms of elevated red blood cell counts and serum creatinine level and decreased serum total protein level. Blood uric acid level negatively correlates with the disease activity of AS, but the effect of high uric acid level on structural injury and functional status of AS is limited.